Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Blood (2009) 114 (22): 2733.

https://doi.org/10.1182/blood.V114.22.2733.2733

Published: 2009

Journal Articles

Deacetylase Inhibitor Cocktails Provide Striking Synergistic Interactions in Human Leukemia Cells.

Michele Cea, MD, Antonia Cagnetta, Floriana Fruscione, Santina Bruzzone, Ph.D., Gabriele Zoppoli, MD, Anna Garuti, Eva Moran, Ph.D., Valentina Grillo, Fabio Ferrando, Salvatore Casciaro, Ivana Pierri, Marco Gobbi, MD, Alberto Ballestrero, MD, Ph.D., Franco Patrone, MD, Ph.D., Alessio Nencioni, MD, Ph.D.

Blood (2009) 114 (22): 4404.

https://doi.org/10.1182/blood.V114.22.4404.4404

Published: 2009

Journal Articles

Regulation of Dendritic Cell Function by Histone Deacetylase Inhibitors.

Julia Beck, Alessio Nencioni, MD, Frank Grünebach, PhD, Anita Bringmann, Lothar Kanz, MD, Franco Patrone, MD, Alberto Ballestrero, MD, Peter Brossart, MD

Blood (2006) 108 (11): 930.

https://doi.org/10.1182/blood.V108.11.930.930

Published: 2006

Journal Articles

Proteasome Inhibitors Affect the Function of Human Dendritic Cells and Induce Caspase-Mediated Apoptosis.

Karin von Schwarzenberg, Alessio Nencioni, MD, Anita Bringmann, Lothar Kanz, MD, Franco Patrone, MD, Alberto Ballestrero, MD, Peter Brossart, MD

Blood (2005) 106 (11): 2229.

https://doi.org/10.1182/blood.V106.11.2229.2229

Published: 2005

Journal Articles

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Anna Garuti, PhD, Adalberto Ibatici, MD, Gabriella Cirmena, PhD, Maurizio Miglino, MD, Riccardo Varaldo, MD, Colombo Nicoletta, PhD, Roberta Grasso, PhD, Sarah Pozzi, PhD, Marina Podesta, PhD, Marco Gobbi, MD, Mario Sessarego, MD, Franco Patrone, MD, Francesco Frassoni, MD

Blood (2005) 106 (11): 3282.

https://doi.org/10.1182/blood.V106.11.3282.3282

Published: 2005

Journal Articles

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Metastatic Breast Cancer.

A.M. Carella, MD, Germana Beltrami, MD, Maria T. Corsetti, MD, Potito Scalzulli, MD, Michele Carella, MD, Roberta Gonella, MD, Alberto Ballestreo, MD, Franco Patrone, MD

Blood (2004) 104 (11): 5129.

https://doi.org/10.1182/blood.V104.11.5129.5129

Published: 2004

NARROW

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Deacetylase Inhibitor Cocktails Provide Striking Synergistic Interactions in Human Leukemia Cells.

Regulation of Dendritic Cell Function by Histone Deacetylase Inhibitors.

Proteasome Inhibitors Affect the Function of Human Dendritic Cells and Induce Caspase-Mediated Apoptosis.

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Metastatic Breast Cancer.

Email alerts

ASH Publications

American Society of Hematology

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Deacetylase Inhibitor Cocktails Provide Striking Synergistic Interactions in Human Leukemia Cells.

Regulation of Dendritic Cell Function by Histone Deacetylase Inhibitors.

Proteasome Inhibitors Affect the Function of Human Dendritic Cells and Induce Caspase-Mediated Apoptosis.

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Metastatic Breast Cancer.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only